Freie Universität Berlin
Investigation of the activation mechanism of the volume-regulated anion channel VRAC and its role in cell proliferation and migration
Abstract
dc:description.abstractThe volume-regulated anion channel (VRAC) is a key player in regulatory volume decrease (RVD) and has been proposed to play pivotal roles in many physiological processes. Although VRAC’s potential physiological functions and activation mechanism were studied extensively, conflicting results were obtained regarding the role of VRAC in cell proliferation and migration, as well as its activation mechanism. The lack of specific pharmacological VRAC inhibitors and the unknown molecular entity of VRAC hampered further progress aiming to elucidate its activation mechanism and proposed physiological roles. The discovery of LRRC8 heteromers as an essential component of VRAC enabled the investigation of its physiological roles and activation mechanism of VRAC using molecular biological tools. Here, I systematically examined the role of VRAC during cell growth and motility for various cell types, including C2C12 myoblasts, HCT116 cells, HEK-293 cells and U251 and U87 glioblastoma cells. Surprisingly, neither pharmacological inhibition of VRAC by carbenoxolone, 4-[(2-Butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy]butanoic acid (DCPIB) or 5-nitro-2-(3-phenylpropyl-amino)benzoic acid (NPPB), nor siRNA-mediated knockdown or disruption of the essential VRAC subunit LRRC8A affected cell proliferation and migration in any of the investigated cell lines. I also found that inhibition of VRAC with DCPIB or siRNA against LRRC8A has no effect on PI3K/Akt signaling in glioblastoma cells. These results indicate that, contrasting the prevailing assumption in the literature, VRAC is dispensable for cell proliferation and migration. Furthermore, by using a Förster-resonance energy transfer (FRET)-based approach, I investigated the potential activation mechanism of VRAC involving protein kinase D (PKD). This revealed that both pharmacological inhibition and siRNA-mediated knockdown of PKDs impaired hypotonicity-induced VRAC activation. Hypotonicity treatment induced the formation of phosphatidic acid (PA) at the plasma membrane. These results corroborate the notion that hypotonicity-induced VRAC activation involves diacylglycerol (DAG) and PA signaling.
Degree
thesis:*- Department dc:contributor.department
- Biologie, Chemie, Pharmazie
- Year dc:date.issued
- 2022
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Liu, Tianbao
- Committee members dc:contributor.committeemember
-
- Stauber, Tobias
- Ewers, Helge
Subjects
dc:subject × 8Rights
dc:rights.accessrights- Statement dc:rights.accessrights
-
- open access
- Licence dc:rights.uri
- Language dc:language
- eng
Identifiers
dc:identifier.*- URN
- urn:nbn:de:kobv:188-refubium-30344-4
- Identifier URI
- http://dx.doi.org/10.17169/refubium-30085